BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Neuron, DNA fingerprint, Doxorubicin, rs2476601, PPARA, Metabolism of xenobiotics)
Bookmark Forward

QuickView for CXCR4 (gene)


Body Atlas

Most Correlated Tissues

  1. Eosinophil of peripheral blood
  2. Leukocyte (polymorphonuclear) of peripheral blood
  3. Basophil of peripheral blood
  4. B lymphocyte (naive) of spleen
  5. Neutrophil of bone marrow
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Chronic fatigue syndrome
  2. Severe combined immunodeficiency disease
  3. Hutchinson-Gilford syndrome
  4. Disorder of neutrophils
  5. Irritable bowel syndrome
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. GDF11 protein, human
  2. R 406 cpd
  3. TNFSF12 protein, human
  4. ascorbate-2-phosphate
  5. Carbonyl Cyanide m-Chlorophenyl Hydrazone
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. ras
  2. HDAC11
  3. ZNF217
  4. HIST1H1B
  5. H1F0
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. CXCR4 and Glioblastoma.
  2. CXCR4 Ligands: The Next Big Hit?
  3. CXCR4-Specific Nanobodies as Potential Therapeutics for WHIM syndrome.
  4. Nuclear Respiratory Factor-1 (NRF-1) Regulates Transcription of the CXC Receptor 4 (CXCR4) in the Ra…
  5. CXCR4 signaling in health and disease.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Autologous CD4 T-Cells in HIV (C34-CXCR4)
  2. Pembrolizumab and CXCR4 Antagonist BL-8040 in Treating Patients With Metastatic Pancreatic Cancer
  3. Imaging CXCR4 Expression in Subjects With Cancer Using 64 Cu-Plerixafor
  4. Chemokine Receptor CXCR4-targeting Molecular Imaging for Metabolic Characterization of Multiple Myel…
  5. CXCR4 Modified Anti-BCMA CAR T Cells for Multiple Myeloma
Explore Clinical Trials Results
  • Copyright © 2023 Illumina Inc. All rights reserved.